A Study of Tanespimycin (KOS-953) in Patients With Relapsed-refractory Multiple Myeloma

Clinical trial NCT00514371 · COMPLETED

Trial details

NCT number: NCT00514371
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2007-08-01
Primary completion: 2009-02-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.